share_log

Oppenheimer Reiterates Outperform on Zura Bio, Lowers Price Target to $16

Benzinga ·  Apr 1 09:33

Oppenheimer analyst Jeff Jones reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment